Celgene calls for Kyle Bass sanctions


Celgene calls for Kyle Bass sanctions

Photo: Courtesy of Celgene ( Celgene Logo, https://www.celgene.com/media-library/celgene-logo/)

Pharmaceutical company Celgene has requested that the US Patent and Trademark Office (USPTO) sanctions hedge fund manager Kyle Bass and his company the Coalition for Affordable Drugs, arguing that the inter partes review (IPR) petitions he has filed are “abusive” and a “tool to affect the stock prices of public companies”.

Celgene; Kyle Bass; Coalition for Affordable Drugs; IPR; PTAB; pharmaceuticals; generics; USPTO